Quick Order Cart

Cat. No. ARG44039

Piezo1 Knockout ATDC-5 Cell Line

  • Product Type:

    In Stock Cell Lines

  • Species:

    Mus musculus (Mouse)

  • Tissue Source:

    Unknown

  • Disease:

    Teratocarcinoma

The Piezo1 Knockout ATDC-5 Cell Line is a CRISPR/Cas9-edited loss-of-function model in mouse ATDC-5 chondrogenic cells for studying mechanotransduction. Piezo1 is a mechanosensitive cation channel that mediates calcium influx and activates calcineurin-NFAT and YAP/TAZ signaling. Key effectors include calpain, calcineurin, NFAT, and TEAD, which regulate chondrocyte differentiation and matrix production. This knockout cell line is ideal for osteoarthritis research, cartilage mechanobiology, and pharmacological screening of Piezo1 inhibitors. Typical assays include calcium imaging with Fluo-4 to measure Piezo1-dependent transients, patch clamp electrophysiology for channel characterization, YAP/TAZ nuclear translocation assays, and mechanical stretch experiments to assess chondrogenic differentiation and ECM production.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    ATDC-5

    Sex of Donor

    Male

    Age

    Embryo

    Gene Name

    Piezo1

    Gene Identifier

    NCBI Gene ID 234839

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The Piezo1 Knockout ATDC-5 Cell Line is a CRISPR/Cas9-edited knockout cell line in which the Piezo1 gene has been disrupted to eliminate functional channel expression in the ATDC-5 mouse chondrogenic cell background. This loss-of-function model enables precise investigation of Piezo1-dependent mechanotransduction, avoiding interference from endogenous wild-type activity. The cell line provides a consistent and scalable platform for studying how mechanical cues are transduced into intracellular responses relevant to cartilage biology and disease.

ATDC-5 cells, derived from mouse teratocarcinoma, are a widely used chondrogenic line that undergoes sequential differentiation from mesenchymal progenitors to hypertrophic chondrocytes upon insulin stimulation, faithfully recapitulating key stages of endochondral ossification and cartilage matrix production. Their well-characterized differentiation profile and ease of culture make them a preferred model for dissecting molecular mechanisms governing chondrogenesis, hypertrophic transition, and cartilage homeostasis in both normal and pathological conditions.

Piezo1 functions as a homotrimeric mechanosensitive non-selective cation channel that opens in response to membrane tension from stretch, shear stress, or cytoskeletal forces, triggering rapid calcium influx. Calcium entry activates calpain and calcineurin, leading to NFAT dephosphorylation and nuclear translocation to regulate transcription. Piezo1 also signals through YAP/TAZ, with calcium-dependent and integrin ??5??1-mediated pathways promoting YAP/TAZ dephosphorylation and TEAD-dependent gene expression. Additionally, Piezo1 couples to MAPK/ERK and AKT cascades, integrating mechanical cues with growth factor responses. Upstream regulators include STOML3, which sensitizes the channel, and sphingomyelinase, which modulates membrane lipid composition; the inhibitory peptide GsMTx4 is widely used for functional studies. The actin cytoskeleton and SERCA also contribute to channel regulation.

In chondrocytes, Piezo1 translates mechanical load into signals regulating matrix synthesis, proliferation, and hypertrophic differentiation. Aberrant activity is implicated in osteoarthritis, where excessive mechanical stress drives catabolic gene expression and cartilage degradation, and in metastasis, where Piezo1 promotes cell migration. This knockout model allows dissection of Piezo1??s role by comparing knockout and parental cells under controlled mechanical conditions such as cyclic stretch or substrate stiffness. It is also valuable for target validation and screening pharmacological modulators.

This knockout cell line supports a broad range of experimental applications. In mechanobiology, it enables calcium imaging with Fluo-4 to quantify Piezo1-dependent calcium transients and patch clamp electrophysiology to characterize channel biophysics. Downstream pathway analysis can be performed via YAP/TAZ nuclear translocation assays, while chondrogenic differentiation can be monitored using RT-qPCR for markers such as Col2a1, Acan, and Col10a1. Mechanical stimulation assays, ECM production assessments, and high-content imaging further facilitate mechanistic studies and drug discovery. For additional information or to discuss custom projects, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)